Monopar Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Monopar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monopar Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monopar Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $544 | 800 | 0.68 |
| 2023-09-30 | $496 | 800 | 0.62 |
| 2023-06-30 | $3.4k | 4.0k | 0.86 |
| 2022-12-31 | $9.5k | 4.0k | 2.37 |
| 2022-06-30 | $9.0k | 4.0k | 2.25 |
| 2022-03-31 | $0 | 4.0k | 0.00 |
| 2021-06-30 | $24k | 4.0k | 6.00 |
| 2020-12-31 | $20k | 3.2k | 6.25 |
| 2020-09-30 | $17k | 3.2k | 5.31 |
| 2020-06-30 | $24k | 3.2k | 7.50 |
| 2020-03-31 | $23k | 3.2k | 7.19 |
| 2019-12-31 | $179k | 11k | 16.80 |